###begin article-title 0
###xml 4 21 4 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 4 20 <span type="species:ncbi:562">Escherichia coli</span>
The Escherichia coli BarA-UvrY two-component system is a virulence determinant in the urinary tract
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 4 24 4 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Salmonella enterica </italic>
###xml 39 58 39 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Erwinia carotovora </italic>
###xml 73 89 73 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Vibrio cholerae </italic>
###xml 107 123 107 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pseudomonas spp </italic>
###xml 207 224 207 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 420 437 420 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 4 23 <span type="species:ncbi:28901">Salmonella enterica</span>
###xml 39 57 <span type="species:ncbi:554">Erwinia carotovora</span>
###xml 73 88 <span type="species:ncbi:666">Vibrio cholerae</span>
###xml 207 223 <span type="species:ncbi:562">Escherichia coli</span>
###xml 420 436 <span type="species:ncbi:562">Escherichia coli</span>
The Salmonella enterica BarA-SirA, the Erwinia carotovora ExpS-ExpA, the Vibrio cholerae BarA-VarA and the Pseudomonas spp GacS-GacA all belong to the same orthologous family of two-component systems as the Escherichia coli BarA-UvrY. In the first four species it has been demonstrated that disruption of this two-component system leads to a clear reduction in virulence of the bacteria. Our aim was to determine if the Escherichia coli BarA-UvrY two-component system is connected with virulence using a monkey cystitis model.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 26 45 26 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Macaque fascularis </italic>
###xml 118 135 118 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 143 148 143 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DS17 </italic>
###xml 175 180 175 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">uvrY </italic>
###xml 342 347 342 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">uvrY </italic>
###xml 527 532 527 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">uvrY </italic>
###xml 650 655 650 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">uvrY </italic>
###xml 973 978 973 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink">uvrY </italic>
###xml 118 134 <span type="species:ncbi:562">Escherichia coli</span>
###xml 634 639 <span type="species:ncbi:9606">human</span>
Cystitis was generated in Macaque fascularis monkeys by infecting the bladder with a 1:1 mixture of the uropathogenic Escherichia coli isolate DS17 and a derivative where the uvrY gene had been disrupted with a kanamycin resistance gene. Urine was collected through bladder punctuation at subsequent time intervals and the relative amount of uvrY mutant was determined. This showed that inactivation of the UvrY response regulator leads to a reduced fitness. In similar competitions in culture flasks with Luria Broth (LB) the uvrY mutant rather had a higher fitness than the wild type. When the competitions were done in flasks with human urine the uvrY mutant initially had a lower fitness. This was followed by a fluctuation in the level of mutant in the long-term culture, with a pattern that was specific for the individual urines that were tested. Addition of LB to the different urine competition cultures however clearly led to a consistently higher fitness of the uvrY mutant.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 553 558 553 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">uvrY </italic>
This paper demonstrates that the BarA-UvrY two-component system is a determinant for virulence in a monkey cystitis model. The observed competition profiles strengthen our previous hypothesis that disruption of the BarA-UvrY two-component system impairs the ability of the bacteria to switch between different carbon sources. The urine in the bladder contains several different carbon sources and its composition changes over time. Inability to efficiently switch between the carbon sources may thus provide an explanation to the reduced fitness of the uvrY mutant in the cystitis model.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
The rapid adjustment of bacteria to new conditions largely relies on two-component systems (TCS). In the prototypic model an environmental stimulus interacts with the N-terminus of a sensor protein, leading to autophosphorylation of a specific histidine residue using ATP. The sensor then acts as a kinase and transmits the phosphate group to a conserved aspartate residue on a cognate response regulator protein. This normally enables the regulator to control the transcription of a certain set of genes by sequence specific DNA binding.
###end p 9
###begin p 10
###xml 18 35 18 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 75 76 75 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 84 101 84 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 252 253 252 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 254 255 254 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 262 279 262 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 303 304 303 304 <underline xmlns:xlink="http://www.w3.org/1999/xlink">b</underline>
###xml 313 314 313 314 <underline xmlns:xlink="http://www.w3.org/1999/xlink">a</underline>
###xml 322 323 322 323 <underline xmlns:xlink="http://www.w3.org/1999/xlink">r</underline>
###xml 386 387 386 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 388 389 388 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 445 450 445 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">csrB </italic>
###xml 454 459 454 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">csrC </italic>
###xml 465 466 465 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 591 593 591 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 722 724 722 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 743 748 743 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">barA </italic>
###xml 751 756 751 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">uvrY </italic>
###xml 765 781 765 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 936 938 936 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 972 989 972 989 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 993 1013 993 1013 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Salmonella enterica </italic>
###xml 1113 1115 1113 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1116 1118 1116 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1119 1121 1119 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 18 34 <span type="species:ncbi:562">Escherichia coli</span>
###xml 84 100 <span type="species:ncbi:562">Escherichia coli</span>
###xml 262 278 <span type="species:ncbi:562">Escherichia coli</span>
###xml 765 781 <span type="species:ncbi:562">Escherichia coli</span>
###xml 972 988 <span type="species:ncbi:562">Escherichia coli</span>
###xml 993 1012 <span type="species:ncbi:28901">Salmonella enterica</span>
Sequencing of the Escherichia coli genome has identified more than 30 TCS [1]. Four Escherichia coli sensor proteins, ArcB, EvgS, TorS and BarA, have two extra domains, D1 and H2, besides the H1 transmitter domain and are thus denoted as 'tripartite' [2-6]. The Escherichia coli tripartite sensor BarA (bacterial adaptive response) forms a TCS with the UvrY response regulator protein [7,8]. UvrY positively controls expression of the noncoding csrB and csrC RNAs [9-11], which bind the 6.8 kD CsrA protein and thus prevent it from interfering with ribosome loading of various target mRNAs [12]. The Csr (carbon storage regulation) system has been shown to have a major impact on regulation on carbon metabolism pathways [13]. Deletion of the barA or uvrY genes in Escherichia coli, as a consequence, has drastic effects on the ability of the bacteria to successfully grow in a competition depending on the carbon source of the medium [14]. Mutations in the Csr system in Escherichia coli and Salmonella enterica also cause other phenotypic effects, including changes in motility, adhesion and biofilm formation [10,15-19].
###end p 10
###begin p 11
###xml 65 84 65 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Salmonella enterica</italic>
###xml 99 117 99 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Erwinia carotovora</italic>
###xml 132 148 132 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Vibrio cholerae </italic>
###xml 165 180 165 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pseudomonas spp</italic>
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 398 410 398 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pseudomonas </italic>
###xml 491 493 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 711 713 711 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 791 795 791 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink">csrB</italic>
###xml 796 801 796 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">csrC </italic>
###xml 895 906 895 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Salmonella </italic>
###xml 907 909 907 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 910 912 910 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 913 915 913 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 65 84 <span type="species:ncbi:28901">Salmonella enterica</span>
###xml 99 117 <span type="species:ncbi:554">Erwinia carotovora</span>
###xml 132 147 <span type="species:ncbi:666">Vibrio cholerae</span>
Deletions of orthologous systems in other bacteria; BarA-SirA in Salmonella enterica, ExpS-ExpA in Erwinia carotovora, BarA-VarA in Vibrio cholerae and GacS-GacA in Pseudomonas spp, clearly diminishes virulence of the bacteria [20,21]. The fact that this system is important for infections in a large spectrum of host organisms has also been corroborated by work demonstrating the necessity of the Pseudomonas GacS-GacA system for infections in either animals, nematodes, insects or plants [22]. The underlying mechanism behind this effect on virulence is far from clear. Several indirect effects have been reported, particularly on the formation of secreted molecules implied in the virulence of the bacteria [20], but the only verified direct target genes are functional homologues to the csrB/csrC regulatory RNAs as well as the genes encoding the HilA and HilC transcriptional regulators in Salmonella [10,23,24].
###end p 11
###begin p 12
###xml 177 197 177 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Salmonella enterica </italic>
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 259 263 259 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">via </italic>
###xml 442 444 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 177 196 <span type="species:ncbi:28901">Salmonella enterica</span>
The nature of a physiological stimulus acting directly on the sensor is still elusive. Bile and intestinal short fatty acids have a clear effect on this two-component system in Salmonella enterica [25,26], although it is unclear if these effects are mediated via the sensor or not. Considering the fact that the system is activated in bacterial monocultures, we earlier proposed that a stimulus reflects the energy/growth status of the cell [14].
###end p 12
###begin p 13
###xml 0 17 0 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 110 112 110 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 115 134 115 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Macaque fascularis </italic>
###xml 218 235 218 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 0 16 <span type="species:ncbi:562">Escherichia coli</span>
###xml 78 83 <span type="species:ncbi:9606">human</span>
###xml 218 234 <span type="species:ncbi:562">Escherichia coli</span>
Escherichia coli is the causative agent in more than 80% of the uncomplicated human urinary tract infections [27]. Macaque fascularis monkeys express the digalactoside receptors to which the P fimbriated uropathogenic Escherichia coli strains bind and thus provide a suitable animal model system to study a cystitis [27]. Here we show that a mutant in the BarA-UvrY two-component system is less fit in a competition in such a cystitis model. We propose that this effect is at least partially mediated by a reduced ability to adapt the carbon metabolism in response to the varying carbon sources in urine.
###end p 13
###begin title 14
Results & discussion
###end title 14
###begin title 15
Monkey cystitis competition assay
###end title 15
###begin p 16
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DS17 </italic>
###xml 99 111 99 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AKP168 uvrY </italic>
###xml 427 428 427 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 504 505 504 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 569 574 569 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">uvrY </italic>
###xml 581 588 581 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AKP168 </italic>
###xml 655 660 655 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DS17 </italic>
###xml 668 670 668 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 882 884 882 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
Two female monkeys were inoculated in the bladder with a 1:1 mixture of the DS17 wild type and the AKP168 uvrY mutant. Urine samples were collected at day 2, 5, 7, 13 and 15 to determine the colony forming units (CFU) and the relative number of wild type and mutant bacteria. Both monkeys exhibited typical symptoms of an acute cystitis as measured by bacteruria and an increased level of leukocyte markers in the urine (Table 1). The infections were cleared naturally by day 13 from both animals (Table 1). Our analysis of the isolated samples clearly showed that the uvrY mutant AKP168 was rapidly lost in both monkeys, in comparison with the wild type DS17 (Figure 1A). On the fifth day of infection more than 95 % of the isolated bacteria were wild type. We also observed a similar take-over of the wild type strain in samples collected from the vagina in these monkeys (Figure 1B). This is expected, as urine continuously contaminates the vagina. We were however unable to perform additional infections as there were no more animals available for such a study.
###end p 16
###begin title 17
The BarA-UvrY two-component system controls the carbon utilization in the cell
###end title 17
###begin p 18
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">uvrY </italic>
###xml 431 433 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 897 899 897 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1356 1358 1356 1358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1463 1468 1463 1468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">csrB </italic>
###xml 1472 1477 1472 1477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">csrC </italic>
###xml 1493 1494 1493 1494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1495 1497 1495 1497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1498 1500 1498 1500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1696 1698 1696 1698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1781 1782 1781 1782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
We recently showed that the ability of a uvrY mutant to grow in a competition culture with the wild type depends on the growth medium, such that the mutant has a higher fitness than the wild type in gluconeogenic media, e.g. LB, but a lower fitness than the wild type in glycolytic media. These results led us to conclude that the BarA-UvrY TCS is important for the bacteria to efficiently switch between different carbon sources [14]. The switching ability is crucial in a glycolytic medium, as long-term growth will change the composition of the medium, with a gradual accumulation of secondary metabolites (e.g. acetate). Accumulated intermediates will in turn be metabolized when the primary metabolites are exhausted. When all carbon sources are depleted from the medium, lysed bacteria will be the only carbon source that can be used. The major carbon source in such lysates is amino acids [28]. In gluconeogenic media, based on amino acids or other small metabolites fuelling directly into the Krebs cycle, the composition of the medium will be relatively unchanged in a long-term culture, including the stage when amino acids from lysed bacteria will be the principal carbon source. Growth in such media is not directly aided by the BarA-UvrY TCS and mutants where the sensor or regulator has been disrupted are rather more fit than the wild type [14]. In support of our hypothesis, the BarA-UvrY TCS has been demonstrated to control transcription of the csrB and csrC noncoding RNAs [9,11,29], which via the CsrA protein regulate the expression of genes involved in gluconeogenis and glycolysis by inversely controlling the concentration of their mRNA at the post-transcriptional level [13]. In the case of csrB, UvrY has been proven to act directly on the csrB promoter [9].
###end p 18
###begin title 19
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">uvrY </italic>
###xml 47 52 <span type="species:ncbi:9606">human</span>
Growth of wild type and uvrY mutant strains in human urine
###end title 19
###begin p 20
###xml 392 394 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 395 397 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
To test if the higher fitness of the wild type bacteria in the monkey cystitis model could be due to their ability to efficiently switch between different carbon sources present in urine we cultivated the bacteria in sterile filtered urine. The composition of urine varies between individual samples, but typically contains a mixture of amino acids, sugars and fatty acids as carbon sources [30,31].
###end p 20
###begin p 21
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DS17 </italic>
###xml 37 44 37 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AKP168 </italic>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 350 355 350 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DS17 </italic>
###xml 373 380 373 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AKP168 </italic>
###xml 574 579 574 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">uvrY </italic>
###xml 676 681 676 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">uvrY </italic>
###xml 756 758 756 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 763 765 763 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 886 891 886 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink">uvrY </italic>
###xml 1463 1470 1463 1470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AKP168 </italic>
###xml 1557 1559 1557 1559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1560 1562 1560 1562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1738 1743 1738 1743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">uvrY </italic>
###xml 1987 1989 1987 1989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 103 108 <span type="species:ncbi:9606">human</span>
###xml 413 418 <span type="species:ncbi:9606">human</span>
We first cultivated the DS17 and the AKP168 strains individually in urine freshly collected from three human subjects (U1, U2 & U3). The growth varied significantly between the individual urines but there was no significant difference in growth between the mutant and the wild type in any of the three urines (Figure 2A). We subsequently allowed the DS17 wild type and the AKP168 mutant to compete in these three human urines. Each competition culture was first split into two and the level of mutant was followed in each culture. In all six urine competitions the level of uvrY mutant decreased during the two first days, but this was followed by an increase in the level of uvrY mutant with a fluctuating pattern that was specific for each urine (Figure 2B and 2C). As urine is a complex medium consisting of a mixture of carbon sources, the initial decrease in the relative level of uvrY mutant may well be explained by its impaired ability to efficiently switch between gluconeogenic and glycolytic carbon sources. The competition profiles were markedly different between the urines but the same in the parallel cultures from the same urine (although with a slight time shift in U3). Our premise that the initial composition of the individual urine determines the competition profile agrees well with this reproducibility. The observed fluctuations after day 1-2 are thus unlikely to be explained by random processes or by spontaneous mutations in either the AKP168 or the wild type strain creating a growth advantage in stationary phase, GASP mutants [32,33]. From the results, it is more likely that each competition profile is decided by the initial composition of each individual urine. To exclude that the reduced fitness of the uvrY mutants in the urine cultures was the result of additional weakening mutations, we demonstrated that mutants taken at day 7 from the different urine competitions could successfully outcompete the wild type strain in a competition in LB (Figure 3A).
###end p 21
###begin p 22
###xml 259 264 259 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">uvrY </italic>
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
The increase in the level of mutant after the initial decrease may be explained by the massive lysis of bacteria after the entry into stationary phase. Lysis will provide an environment with an excess of gluconeogenic carbon sources, where it is known that a uvrY mutant has a growth advantage [14].
###end p 22
###begin p 23
###xml 194 199 194 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">uvrY </italic>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 404 409 404 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">uvrY </italic>
We also repeated the competition in the same urines (U1, U2 & U3) complemented with LB. In these competitions where there is a constant excess of gluconeogenic carbon sources in the medium, the uvrY mutant rapidly outcompeted the wild type (Figure 3B), similar to what is observed in LB alone (Figure 3A). Thus, there seems to be no dominant factor in urine that would explain the lowered fitness of the uvrY mutant.
###end p 23
###begin p 24
###xml 148 153 148 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">uvrY </italic>
###xml 433 445 433 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pseudomonas </italic>
###xml 624 635 624 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arabidopsis</italic>
###xml 638 640 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 624 635 <span type="species:ncbi:3702">Arabidopsis</span>
Although our model system cannot mimic the exact conditions in the bladder, such as the continuous addition of fresh urine, the data suggest that a uvrY mutant has an impaired ability to efficiently metabolize the different nutrient components in the urine. This also emphasizes that an optimal growth rate is critical for bacteria during an infection. In analogy with our results, it is interesting to note that long-term growth of Pseudomonas strains in gluconeogenic media selects for strains with inactivating mutations in the orthologous GacS-GacA system, unlike when the same strains are tested in an infection model (Arabidopsis) [34]. It would be interesting to test what role the described metabolic switches plays in the other bacterial species where it is known that the BarA-UvrY two-component system family affects virulence.
###end p 24
###begin p 25
###xml 109 114 109 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">uvrY </italic>
###xml 137 145 137 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 302 304 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
We cannot exclude that other factors under the control of this TCS contributes to the lowered fitness of the uvrY mutant observed in the in vivo cystitis model. Earlier studies have demonstrated effects of the BarA-UvrY TCS and the downstream Csr system on adhesion, aggregation and biofilm formation [10,15-19], all of which may play a role in the persistence of bacteria in the bladder in concert with the ability to utilize and switch between glycolytic and gluconeogenic carbon sources.
###end p 25
###begin title 26
Conclusion
###end title 26
###begin p 27
###xml 359 364 359 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">uvrY </italic>
###xml 568 573 568 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">uvrY </italic>
###xml 633 638 633 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">uvrY </italic>
This paper demonstrates that the BarA-UvrY system is a determinant for virulence in a monkey cystitis model. Based on different competition profiles we propose that the BarA-UvrY TCS is important for the bacteria to efficiently switch between different carbon sources present in urine. This would provide a plausible explanation to the reduced fitness of the uvrY mutant in the cystitis model as urine consists of several different carbon sources and as the prevalent carbon sources will change over time. This also agrees well with the observed higher fitness of the uvrY mutant in competitions in purely gluconeogenic media as the uvrY mutant is predisposed for gluconeogenesis. In conclusion, the ability to grow quickly and benefit from the available carbon and energy sources is crucial for virulence. During infection there may be different carbon sources available and we believe that the ability to know when to metabolize them is in part conferred by the BarA-UvrY two-component system.
###end p 27
###begin title 28
Methods
###end title 28
###begin title 29
Monkey cystitis competition model
###end title 29
###begin p 30
###xml 17 36 17 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Macaque fascularis </italic>
###xml 110 112 110 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8 </sup>
###xml 154 159 154 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DS17 </italic>
###xml 186 191 186 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">uvrY </italic>
###xml 198 204 198 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AKP168</italic>
###xml 331 336 331 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DS17 </italic>
###xml 473 474 473 474 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 882 883 882 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1242 1247 1242 1247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DS17 </italic>
###xml 408 411 <span type="species:ncbi:31658">CFA</span>
###xml 448 453 <span type="species:ncbi:4932">yeast</span>
###xml 1225 1231 <span type="species:ncbi:3635">cotton</span>
Two adult female Macaque fascularis monkeys were infected by inoculation of a bacterial suspension (1 ml of 108 bacteria/ml), containing equal amounts of DS17 wild type and the isogenic uvrY mutant AKP168, into the bladder using a catheter (the bladder void volume is approximately 150 ml). The monkeys had not been exposed to the DS17 strain earlier. Bacteria had been taken from fresh colony forming agar (CFA) plates (10 g Casamino acids, 1.5 g yeast extract, 50 mg MgSO4, 5 mg MnCl, 15 g Bacto agar per liter) and resuspended in phosphate buffered saline (PBS). Inocula were directly analyzed on selective plates to assure that the level of mutant was close to 50 %. Samples from monkeys were collected by suprapubic bladder aspiration, using a syringe with vacutainer, at the time points indicated until two successive negative cultures were obtained (day 13 and day 15; Table 1). The animals were then considered healthy and removed from the study. At 20-30 min before bladder aspiration, monkeys were hydrated with approximately 50 ml of lukewarm saline administered subcutaneously in the neck for optimal diuresis. All experiments were done under ketamine and midazolam anesthesia. Vaginal smears were collected with cotton swabs. No DS17 bacteria could be isolated from the feces of the monkeys before or after the infection. Monkeys were kept in the animal facility at the Swedish Institute for Infectious Disease Control (SMI) in 80 x 70 x 170 cm (width, depth, and height) cages, two in each, and were handled by professional personnel according to SMI regulations. Experiments were pre-approved by the local ethics committee in Stockholm.
###end p 30
###begin title 31
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
In vitro growth of strains
###end title 31
###begin p 32
###xml 43 60 43 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 67 72 67 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DS17 </italic>
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 85 92 85 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AKP168 </italic>
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 118 123 118 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">uvrY </italic>
###xml 178 185 178 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AKP168 </italic>
###xml 259 264 259 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DS17 </italic>
###xml 342 344 342 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 43 59 <span type="species:ncbi:562">Escherichia coli</span>
In this work we employed the uropathogenic Escherichia coli strain DS17 [35] and the AKP168 derivative [14], with the uvrY gene disrupted by a kanamycin resistance cassette. The AKP168 mutant exhibited no measurable difference in growth relative the parental DS17 strain in a range of different media, as measured by optical density and CFU [14].
###end p 32
###begin p 33
###xml 151 156 <span type="species:ncbi:9606">human</span>
###xml 393 398 <span type="species:ncbi:4932">yeast</span>
Growth was normally conducted in a 20 ml volume in 100 ml Erlenmeyer glass flasks at 37degreesC in a shaker with 200 rpm. Urine collected from healthy human male donors was centrifuged at 4000 rpm and sterile filtered through a 0.45 muM CA-filter (Corning Inc., NY). Urine-LB was prepared by mixing four parts of sterile filtered urine with one part of 5 x LB (50 g Bacto tryptone, 25 g Bacto yeast extract and 50 g NaCl per liter).
###end p 33
###begin p 34
###xml 113 118 <span type="species:ncbi:4932">yeast</span>
In growth curve experiments each strain was grown as an over night culture in LB (10 g Bacto tryptone, 5 g Bacto yeast extract, 10 NaCl per liter) started directly from a -80degreesC vial), washed twice in PBS, inoculated 1:100 in 20 ml urine. 1 ml samples were withdrawn and the optical density was measured at 600 nm at the indicated time points with a spectrophotometer.
###end p 34
###begin p 35
###xml 234 238 228 232 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600 </sub>
In competition experiments each strain was grown as an over night culture in LB (started directly from a -80degreesC vial), washed twice in PBS, inoculated 1:100 in urine, urine-LB, or plain LB, and grown as an individual culture to A600 = 0.15-0.30. Subsequently, cultures were mixed 1:1 to a 20 ml volume. Samples of 100 mul were withdrawn at the indicated time intervals and subjected to appropriate dilution in PBS. Dilutions were added to Luria-Bertani plates, with or without kanamycin (10 mug/ml), together with 5 to 6 glass beads (6 mm diameter) (Stern Walter Inc, NY, USA). Plates were gently agitated for 20 seconds to evenly spread the bacteria over the plate, after which the beads were removed. The relative level of mutant was calculated by dividing the number of colonies growing on the selective plate with the number of colonies growing on the non-selective plate.
###end p 35
###begin title 36
Authors' contributions
###end title 36
###begin p 37
HT, AKP and KJ carried out the experimental work. RM provided expertise for the primate experiments. All authors have been involved in the design and planning of the experiments and the drafting of the manuscript. OM coordinated the study. All authors read and approved the final manuscript.
###end p 37
###begin title 38
Acknowledgements
###end title 38
###begin p 39
This work was supported by grants from the Swedish Research Council. KJ has been supported by a Marie Curie Early Stage Research Training Fellowship of the European Community's Sixth Framework Programme under contract number MEST-CT-2004-8475. We thank Peter Kjall for discussions.
###end p 39
###begin article-title 40
###xml 100 116 <span type="species:ncbi:562">Escherichia coli</span>
Compilation of all genes encoding two-component phosphotransfer signal transducers in the genome of Escherichia coli
###end article-title 40
###begin article-title 41
###xml 86 102 <span type="species:ncbi:562">Escherichia coli</span>
In vitro phosphorylation study of the arc two-component signal transduction system of Escherichia coli
###end article-title 41
###begin article-title 42
###xml 126 142 <span type="species:ncbi:562">Escherichia coli</span>
Transphosphorylation of the TorR response regulator requires the three phosphorylation sites of the TorS unorthodox sensor in Escherichia coli
###end article-title 42
###begin article-title 43
###xml 76 92 <span type="species:ncbi:562">Escherichia coli</span>
Phosphotransfer circuitry of the putative multi-signal transducer, ArcB, of Escherichia coli: in vitro studies with mutants
###end article-title 43
###begin article-title 44
###xml 71 91 <span type="species:ncbi:520">Bordetella pertussis</span>
Integration of multiple domains in a two-component sensor protein: the Bordetella pertussis BvgAS phosphorelay
###end article-title 44
###begin article-title 45
###xml 47 63 <span type="species:ncbi:562">Escherichia coli</span>
Genetic and functional characterization of the Escherichia coli BarA-UvrY two-component system: point mutations in the HAMP linker of the BarA sensor give a dominant-negative phenotype
###end article-title 45
###begin article-title 46
###xml 18 34 <span type="species:ncbi:562">Escherichia coli</span>
Regulation of the Escherichia coli excision repair gene uvrC. Overlap between the uvrC structural gene and the region coding for a 24 kD protein
###end article-title 46
###begin article-title 47
###xml 87 103 <span type="species:ncbi:562">Escherichia coli</span>
Identification of UvrY as the cognate response regulator for the BarA sensor kinase in Escherichia coli
###end article-title 47
###begin article-title 48
###xml 63 79 <span type="species:ncbi:562">Escherichia coli</span>
Regulatory circuitry of the CsrA/CsrB and BarA/UvrY systems of Escherichia coli
###end article-title 48
###begin article-title 49
Pathways leading from BarA/SirA to motility and virulence gene expression in Salmonella
###end article-title 49
###begin article-title 50
###xml 66 82 <span type="species:ncbi:562">Escherichia coli</span>
A novel sRNA component of the carbon storage regulatory system of Escherichia coli
###end article-title 50
###begin article-title 51
###xml 34 50 <span type="species:ncbi:562">Escherichia coli</span>
CsrA regulates translation of the Escherichia coli carbon starvation gene, cstA, by blocking ribosome access to the cstA transcript
###end article-title 51
###begin article-title 52
Global regulation by the small RNA-binding protein CsrA and the non-coding RNA molecule CsrB
###end article-title 52
###begin article-title 53
###xml 4 20 <span type="species:ncbi:562">Escherichia coli</span>
The Escherichia coli BarA-UvrY two-component system is needed for efficient switching between glycolytic and gluconeogenic carbon sources
###end article-title 53
###begin article-title 54
###xml 47 63 <span type="species:ncbi:562">Escherichia coli</span>
Periodicity of cell attachment patterns during Escherichia coli biofilm development
###end article-title 54
###begin article-title 55
###xml 25 41 <span type="species:ncbi:562">Escherichia coli</span>
Catabolite repression of Escherichia coli biofilm formation
###end article-title 55
###begin article-title 56
###xml 84 100 <span type="species:ncbi:562">Escherichia coli</span>
Biofilm formation and dispersal under the influence of the global regulator CsrA of Escherichia coli
###end article-title 56
###begin article-title 57
###xml 112 128 <span type="species:ncbi:562">Escherichia coli</span>
CsrA post-transcriptionally represses pgaABCD, responsible for synthesis of a biofilm polysaccharide adhesin of Escherichia coli
###end article-title 57
###begin article-title 58
###xml 88 104 <span type="species:ncbi:562">Escherichia coli</span>
Positive regulation of motility and flhDC expression by the RNA-binding protein CsrA of Escherichia coli
###end article-title 58
###begin article-title 59
Regulatory roles of the GacS/GacA two-component system in plant-associated and other gram-negative bacteria
###end article-title 59
###begin article-title 60
###xml 30 69 <span type="species:ncbi:90371">Salmonella enterica serovar Typhimurium</span>
###xml 128 132 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Microarray-based detection of Salmonella enterica serovar Typhimurium transposon mutants that cannot survive in macrophages and mice
###end article-title 60
###begin article-title 61
Plants and animals share functionally common bacterial virulence factors
###end article-title 61
###begin article-title 62
###xml 63 78 <span type="species:ncbi:666">Vibrio cholerae</span>
CsrA and three redundant small RNAs regulate quorum sensing in Vibrio cholerae
###end article-title 62
###begin article-title 63
###xml 71 94 <span type="species:ncbi:294">Pseudomonas fluorescens</span>
Three small RNAs jointly ensure secondary metabolism and biocontrol in Pseudomonas fluorescens CHA0
###end article-title 63
###begin article-title 64
###xml 41 63 <span type="species:ncbi:90371">Salmonella typhimurium</span>
Intestinal short-chain fatty acids alter Salmonella typhimurium invasion gene expression and virulence through BarA/SirA
###end article-title 64
###begin article-title 65
###xml 0 19 <span type="species:ncbi:28901">Salmonella enterica</span>
Salmonella enterica serovar typhimurium invasion is repressed in the presence of bile
###end article-title 65
###begin article-title 66
Clinical presentations and epidemiology of urinary tract ifections
###end article-title 66
###begin article-title 67
Mutations enhancing amino acid catabolism confer a growth advantage in stationary phase
###end article-title 67
###begin article-title 68
###xml 87 126 <span type="species:ncbi:90371">Salmonella enterica serovar Typhimurium</span>
Identification of CsrC and characterization of its role in epithelial cell invasion in Salmonella enterica serovar Typhimurium
###end article-title 68
###begin article-title 69
###xml 38 43 <span type="species:ncbi:9606">human</span>
Variation in urine composition in the human urinary tract: evidence of urothelial function in situ?
###end article-title 69
###begin article-title 70
###xml 16 21 <span type="species:ncbi:9606">human</span>
Metabolomics in human nutrition: opportunities and challenges
###end article-title 70
###begin article-title 71
GASPing for life in stationary phase
###end article-title 71
###begin article-title 72
###xml 0 16 <span type="species:ncbi:562">Escherichia coli</span>
Escherichia coli evolution during stationary phase
###end article-title 72
###begin article-title 73
###xml 68 91 <span type="species:ncbi:294">Pseudomonas fluorescens</span>
Characterization of spontaneous gacS and gacA regulatory mutants of Pseudomonas fluorescens biocontrol strain CHAO
###end article-title 73
###begin article-title 74
###xml 87 103 <span type="species:ncbi:562">Escherichia coli</span>
###xml 107 115 <span type="species:ncbi:9606">children</span>
Epidemic outbreaks of acute pyelonephritis caused by nosocomial spread of P fimbriated Escherichia coli in children
###end article-title 74
###begin title 75
Figures and Tables
###end title 75
###begin p 76
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">uvrY </italic>
###xml 0 61 0 61 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The <italic>uvrY </italic>deletion mutant is outcompeted in the monkey bladder</bold>
###xml 80 85 80 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DS17 </italic>
###xml 89 96 89 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AKP168 </italic>
###xml 272 279 272 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AKP168 </italic>
The uvrY deletion mutant is outcompeted in the monkey bladder. A 1:1 mixture of DS17 and AKP168 mutant was inoculated into the bladder of 2 individual monkeys (110-7 and 40-6) at day 0. Urine samples and vaginal smears were collected (day 2, 5 & 7). The percentage of the AKP168 mutant was determined in A. urine and B. vaginal smears.
###end p 76
###begin p 77
###xml 33 42 33 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 0 68 0 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Growth of individual strains and <italic>In vitro </italic>competition in human urine</bold>
###xml 73 78 73 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DS17 </italic>
###xml 100 107 100 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AKP168 </italic>
###xml 139 148 139 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 213 218 213 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DS17 </italic>
###xml 222 229 222 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AKP168 </italic>
###xml 379 386 379 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AKP168 </italic>
###xml 452 457 452 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DS17 </italic>
###xml 489 496 489 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AKP168 </italic>
###xml 57 62 <span type="species:ncbi:9606">human</span>
###xml 167 172 <span type="species:ncbi:9606">human</span>
###xml 269 274 <span type="species:ncbi:9606">human</span>
Growth of individual strains and In vitro competition in human urine. A. DS17 (filled diamonds) and AKP168 (squares) were grown separately in vitro in three different human urines (U1, U2 & U3). B. 1:1 mixture of DS17 and AKP168 mutant was grown in the three different human urines (U1, U2 & U3) and samples were taken at the indicated time points to determine the percentage of AKP168 mutant. C. The same competitions as in B. but plotted as CFU with DS17 depicted as filled diamonds and AKP168 as squares.
###end p 77
###begin p 78
###xml 0 56 0 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink">In vitro competition in human urine complemented with LB</bold>
###xml 79 84 79 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">uvrY </italic>
###xml 105 112 105 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AKP168 </italic>
###xml 237 242 237 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DS17 </italic>
###xml 328 335 328 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AKP168 </italic>
###xml 24 29 <span type="species:ncbi:9606">human</span>
In vitro competition in human urine complemented with LB. A. Re-competition of uvrY mutants in LB. Three AKP168 individual mutant clones were isolated at day seven from the urine competitions (U1, U2 & U3) and competed against wild type DS17 in LB. Samples were taken at the indicated time points to determine the percentage of AKP168 mutant. B. The same experiment as in Figure 2B but the urine was complemented with LB (see Materials & Methods).
###end p 78
###begin p 79
Leukocyte markers and CFU
###end p 79
###begin p 80
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
aPresence of leukocytes was determined by the ECUR-dip stick test (Boehringer-Mannheim). Color changes of grades 1, 2 and 3 correspond to 10-25, approximately 75, and approximately 500 granulocytes/ml, respectively.
###end p 80
###begin p 81
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
bIdentification number for the individual monkeys.
###end p 81

